Pharmaceutical composition for treating leucopenia
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A leukopenia and composition technology, applied in the field of medicine, can solve problems such as large side effects, high price, and restrictions on drug promotion
Inactive Publication Date: 2013-04-24
朱家红
View PDF0 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine often uses drugs such as batalinol, lexogen, and Ruibai for treatment, but the curative effect is poor and the side effects are relatively large
Altho
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0037] 5 parts of American ginseng, 3 parts of Astragalus, 2 parts of Panax notoginseng, 3 parts of Ganoderma lucidum
[0038] Ligustrum lucidum 3 parts Caulis Spatholobus 6 parts Lycium barbarum 3 parts Paeoniae Alba 3 parts
[0039] 3 parts of psoralen, 2 parts of donkey-hide gelatin, 3 parts of tangerine peel
Embodiment 2
[0041] 8 parts of American Ginseng, 5 parts of Astragalus, 5 parts of Panax notoginseng, 8 parts of Ganoderma lucidum
[0042] 8 parts of Ligustrum lucidum, 10 parts of Caulis Spatholobus, 8 parts of medlar, 8 parts of white peony
[0043] 8 parts of psoralen, 5 parts of donkey-hide gelatin, 8 parts of tangerine peel
Embodiment 3
[0045] 6 parts of American ginseng, 4 parts of Astragalus, 3 parts of Panax notoginseng, 6 parts of Ganoderma lucidum
[0046] Ligustrum lucidum 6 parts, Caulis Spatholobus 8 parts, Lycium barbarum 6 parts, Paeoniae Alba 5 parts
[0047] 5 parts of psoralen, 4 parts of donkey-hide gelatin, 6 parts of tangerine peel
[0048] Application of the above composition in the treatment of leukopenia.
[0049] The above composition can be made into any existing clinically applicable dosage form in pills, capsules, tablets, granules and oral liquids according to the prior art.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a pharmaceutical composition for treating leucopenia. The composition researched by using the basic theory of the traditional Chinese medicine consists of American ginseng, astragalus root, pseudo-ginseng, ganoderma lucidum, glossy privet fruit, suberect spatholobus stem, medlar, white peony root, fructus psoraleae, donkey-hide glue, dried orange peel and the like which are used as Chinese medicinal raw materials. The composition has the effects of nourishing liver and kidney and tonifying qi and blood, and is clinically used for treating the leucopenia produced after malignant tumor radiotherapy and chemotherapy.
Description
technical field [0001] The invention relates to a pharmaceutical composition for treating leukopenia, more specifically, a traditional Chinese medicine composition which has the functions of nourishing liver and kidney, benefiting qi and blood, and is used for leukopenia caused by radiotherapy and chemotherapy of malignant tumors, which belongs to medicine technology field. Background technique [0002] Leukopenia is a common blood disease and belongs to the category of asthenia and blood deficiency in traditional Chinese medicine. Doctor trained in Western medicine uses the medicine treatment such as batyl alcohol, lexogen, Ruibai more, but curative effect is relatively poor, and side effect is bigger. Although the granulocyte colony factor used in recent years has a certain curative effect, it is expensive and has many side effects, which limit the promotion of the drug. [0003] The TCM syndrome differentiation of leukopenia belongs to deficiency of both qi and blood, d...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more